A process of formulation for Calcium Benzamidosalicylate, the film coated tablet. The film coated tablet comprising the core consisting of therapeutically effective dose of Calcium Benzamidosalicylate and hydrophilic outer coating in terms of film coating.

This invention describes a composition for combating Mycobacterium tuberculosis using tuberculosis line 1 and tuberculosis line 3 inhibiters, such as isoniazide and thiacetazone respectively, useful for oral administration and capable for pharmaceutical application. The invention further relates to the pharmaceutica...

The present invention specially relates to the crystalline form of  (4-Nitrobenzyl (4R.5S,6S)-(3-{(3S,5S)-5-[(dimethylamino)carbonyi]-l-[(4-nitrophenoxy)carbonxyl] pyrroIidin-3-yl}thio-6- [(lR)-l-hydorxyethyl]-4-methyl-7-oxo-l-azabicyclo[3.2.0].hept-2-ene-2-carboxylate)of compound formula -I   as well as an improved...

The present invention mainly describes a novel process with novel intermediate, industrially applicable without hazardous raw materials. The compound formula (I): Which is mainly used in antidepressant drug. Miratazapine disclosed

The present invention relates to improved process for preparation of meropenem trihydrate Structure-I (4R,5S,6S)-3-[[(3S,5S)-5-(Dimethylcarbamoyl)-3-pyrrolidinyl]thio]-6-[(lR)-l- hydroxy-ethyl]-4-methyl-7-oxo-l-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid) and its penultimate stage intermediate(4-Nitrobenzyl(4R,5S,...